Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1996
09/19/1996WO1996028559A1 Method for the production of cationic peptides
09/19/1996WO1996028555A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same
09/19/1996WO1996028553A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2
09/19/1996WO1996028550A1 Human restrictin and nucleic acid sequences
09/19/1996WO1996028548A1 Receptor activation by gas6
09/19/1996WO1996028547A1 Dermatomyositis-specific auto-antigen
09/19/1996WO1996028546A1 Human tumor necrosis factor receptor
09/19/1996WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996WO1996028543A1 New defined enzyme mixtures for obtaining cells and treating wounds
09/19/1996WO1996028537A1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome
09/19/1996WO1996028475A1 Peg-modified hgf
09/19/1996WO1996028473A1 Human monoclonal antibody against lung carcinoma
09/19/1996WO1996028471A1 Modulators of amyloid aggregation
09/19/1996WO1996028470A2 Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
09/19/1996WO1996028469A1 Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof
09/19/1996WO1996028468A2 Amphiphilic peptide and analogs thereof
09/19/1996WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
09/19/1996WO1996028466A1 Peptides inhibiting phospholipase c
09/19/1996WO1996028465A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028464A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028463A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028214A2 Treatment of pulmonary hypertension with a bombesin antagonist
09/19/1996WO1996028189A1 A double transdominant fusion gene and protein
09/19/1996WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
09/19/1996WO1996028185A2 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
09/19/1996WO1996028183A1 Method for treatment of autoimmune diseases using interferon-tau
09/19/1996WO1996028182A1 Method of preventing tpo adsorption and stable tpo-containing composition
09/19/1996WO1996028181A1 Method of preventing tpo adsorption and stable tpo-containing composition
09/19/1996WO1996028180A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
09/19/1996WO1996028179A1 Applications of halocine h7
09/19/1996WO1996028169A1 Glycoconjugate inhibitors of human sperm-egg binding
09/19/1996WO1996028145A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
09/19/1996WO1996028143A1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
09/19/1996WO1996028142A1 Method and kit for preventing erectile dysfunction
09/19/1996WO1996028114A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996WO1996021463A3 New applications of lysozyme dimer
09/19/1996WO1996019499A3 Improved cyclic crf antagonists
09/19/1996WO1996019233A3 Irrigation solution and method for inhibition of pain, inflammation and spasm
09/19/1996WO1996018736A3 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
09/19/1996WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
09/19/1996WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage
09/19/1996DE4090006C2 Purified sciatic nerve ciliary neurotrophic factor
09/19/1996DE19532906A1 Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung New, defined mixtures of enzymes for cell recovery and for the treatment of wounds
09/19/1996DE19518931C1 New polymorphic regions in the B2-bradykinin receptor gene
09/19/1996DE19509792A1 Mittel zur Beeinflussung der Zelldifferenzierung und seine Verwendung Means for influencing cell differentiation, and its use
09/19/1996CA2449296A1 Modulators of amyloid aggregation
09/19/1996CA2215383A1 Human tumor necrosis factor receptor
09/19/1996CA2215362A1 Method for the production of cationic peptides
09/19/1996CA2215315A1 Methods for preventing adsorption of thrombopoietin (tpo) and stable tpo-containing compositions
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2215249A1 Methods for preventing adsorption of thrombopoietin (tpo) and stable tpo-containing compositions
09/19/1996CA2215061A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215025A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2215022A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996CA2214999A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes
09/19/1996CA2214823A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation
09/19/1996CA2214646A1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome
09/19/1996CA2214490A1 Method for treatment of autoimmune diseases using interferon-tau
09/19/1996CA2214010A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996CA2213723A1 New defined enzyme mixtures for obtaining cells and treating wounds
09/19/1996CA2189674A1 Peptides inhibiting phospholipase c
09/19/1996CA2189252A1 Human restrictin and nucleic acid sequences
09/18/1996EP0732401A2 Megakaryocyte stimulating factor (meg-CSF)
09/18/1996EP0732399A2 Chymotrypsin-like proteases and their inhibitors
09/18/1996EP0732397A2 Modified hepatocytes and uses therefor
09/18/1996EP0732339A1 Peptides of the HIV-gag protein, their preparation and use
09/18/1996EP0732102A2 Composite for the treatment of acute myocardial infarction containing hirudin and acetylsalicyclic acid
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731838A1 Binding structures directed against the ca55.1 antigen
09/18/1996EP0731811A1 Chaperonin 10
09/18/1996EP0731810A1 Double-chain hemoregulatory peptides
09/18/1996EP0731807A1 N-2 substituted purines
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
09/18/1996EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
09/18/1996EP0731710A1 Method and composition for treatment of patients having decompensated liver disease
09/18/1996EP0731709A1 Novel neutrophil inhibitors
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996EP0731688A1 Aerosol drug formulations for use with non-cfc propellants
09/18/1996EP0731636A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
09/18/1996EP0643780B1 Multiple solvent cleaning system
09/18/1996EP0637964B1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy
09/18/1996EP0629244B1 Pathogen-targeted biocatalyst
09/18/1996EP0593625B1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
09/18/1996EP0482133B1 Use of lactoferrin to counter the toxic effects of endotoxins
09/18/1996CN1131438A Protein having TPO activity
09/18/1996CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
09/18/1996CN1131326A Luminous hand of electrolumines cence
09/18/1996CN1131192A Recombinant mersacidin and method for production
09/18/1996CN1131159A Bromelin decrustation preparation and its preparing method
09/18/1996CN1131153A 1-oxy-2-(phenylsulfonamido-) amyl piperidine derivant, its preparation method and medicinal use thereof
09/18/1996CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them
09/18/1996CN1131040A Preventing and curing agent for intestinal disease of chicken and its preparation method
09/18/1996CN1131039A Polypeptide drug composition suitable for administration through eye and preparation method thereof
09/18/1996CN1032787C Synergistic treatment method
09/17/1996US5557033 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide
09/17/1996US5557032 Knockout mice
1 ... 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 ... 3163